Unrelated cord blood transplants in adults with hematologic malignancies

Haematologica

Volumn 91, Issue 2, 2006, Pages 223-230

  Arcese, William ^a   Rocha, Vanderson ^a   Labopin, Myriam ^a   Sanz, Guillermo ^a   Iori, Anna Paola ^a   De Lima, Marcos ^a   Sirvent, Anne ^a   Busca, Alessandro ^a   Asano, Shigheta ^a   Ionescu, Irina ^a   Wernet, Peter ^a   Gluckman, Eliane ^a,b  

^a Eurocord Netcord ^*  (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Adults; Hematologic malignancies; Unrelated cord blood transplants

Indexed keywords

HEMOPOIETIC GROWTH FACTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; CAUSE OF DEATH; CELL SURVIVAL; CHRONIC LEUKEMIA; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPHIL COUNT; OVERALL SURVIVAL; RECURRENT DISEASE;

ADOLESCENT; ADULT; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOLOGIC NEOPLASMS; HUMANS; MIDDLE AGED; NEUTROPHILS; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 33644545417     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335:157-66.
2. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, et al. Outcome of cord blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997;337:373-81.
3. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
4. Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood 1999;93:3662-7
5. Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang M-J, Horowitz MM, et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med 2000;342:1846-154.
6. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001;97:2962-71.
7. Barker JN, Davies SM, DeFor T, Ramsay NKC, Weisdorf DJ, Wagner JE. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001;97: 2957-61.
8. Wagner JE, Barker JN, DeFor TE, Baker S, Blazar BR, Eide C, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non malignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611-18.
9. Michel G, Rocha V, Chevret S, Arcese W, Chan K-W, Filipovich A, et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 2003;102:4290-7.
10. Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003;101:4233-44.
11. Wernet P. The Netcord inventory and use [Netcord web site]. January 2004. Available at: http://www.netcord.org/inventory.gif. Accessed March 3, 2004.
12. Bone marrow transplants: despite recruitment successes, national programs may be underutilized. Washington, D.C.: U.S. General Accounting Office. 2002. (GAO-03-182) Available at: http://www.gao.gov/new.items/d03182.pdf. Accessed November 3, 2004.
13. Kollman C, Abella E, Baitty RL, Beatty PG, Chakraborty R, Christiansen CL, et al. Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors. Transplantation 2004;78:89-95.
14. Lansdorp PM, Dragowska W, Mayani H. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 1993;178:787-91.
15. Frassoni F, Podestà M, Maccario R, Giorgiani G, Rossi G, Zecca M, et al. Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation. Blood 2003;102:1138-41.
16. Laughlin MJ, Barker J, Bambach B, Omeb NK, Rizzieri DA, Wagner JE, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815-22.
17. Sanz GF, Saavedra S, Planelles D, Senent L, Cervera J, Barragan E, et al. Standardized, unrelated donor cord blood transplantation in adults with hematological malignancies. Blood 2001;98:2332-8.
18. Ooi J, Iseki T, Takahashi S, Tomonari A, Ishii K, Takasugi K, et al. Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood 2003;101:4711-3.
19. Ooi J, Iseki T, Takahashi S, Tomonari A, Takasugi K, Shimohakamada Y, et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004;103:489-91.
20. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang M-J, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004;351:2265-7.
21. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Comparison of outcomes after unrelated umbilical cord blood versus unrelated bone marrow transplants in adults with acute leukemia. New Engl J Med 2004;351:2276-85.
22. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Taylor PE, et al. Processing and cryopreservation of placental-umbilical cord blood for unrelated marrow reconstitution. Proc Natl Acad Sci USA 1995;92:101-19.
23. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL A-matched sibling donors. Transplantation 1974;18:295-304.
24. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69:204-17.
25. Cox DR. Regression models and life tables. J Royal Stat Soc 1972;34 Series B: 187-220.
26. Gooley TA, Leisenring W, Crowley JA, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:665-706.
27. Fine JP, Gray RJ. A proportional hazards model for subdistribution of a competing risk. J Am Stat Ass 1999;94:496-509.
28. Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan KW, et al. On behalf of Eurocord group. Factors associated with outcome of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004;32:397-407.
29. Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P, et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000;96:2717-22.
30. Ion AP, Cerretti R, De Felice L, Screnci M, Mengarelli A, Romano A, et al. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation. Bone Marrow Transplant 2004;33:1097-105.
31. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993;328:593-602.
32. Szydlo R, Goldman JM, Klein, Gale RP, Ash RC, Bach FH, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997;15: 1767-77.
33. Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW, et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 1997;89:4226-35.
34. Petersdorf EW, Gooley TA, Anasetti C, Martin PJ, Smith AG, Mickelson EM, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998;92: 3515-20.
35. Harris DT, Schumacher MJ, Locascio J, Besencon FJ, Olson GB, DeLuca D, et al. Phenotypic and functional immaturity of human umbilical cord blood lymphocytes. Proc Nat Acad Sci USA 1992;89: 1006-10.
36. McDouall RM, Suitters AJ, Smith H, Yacoub MH, Rose ML, et al. Increased cyclosporine sensitivity of T cells from cord blood compared with those from the adult. Clin Exp Immunol 1994;95:519-24.
37. Hamza NS, Lisgaris M, Yadavalli G, Nadeau L, Fox R, Fu P et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol 2004;124:488-98.
38. Klein AK, Patel DD, Gooding ME, Sempowski GD, Chen BJ, Liu C, et al. T-cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant 2005;7:454-66.
39. Sasazuki T, Juji T, Morishima Y, Kinukawa N, Kashiwabara H, Inoko H, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 1998;339: 1177-85.
40. Flomenberg N, Baxter-Lowe LN, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M, et al. Impact of class I and class II high resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplant outcome. Blood 2004;104: 1923-30.
41. Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001;344:1870-1.
42. Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002;8:363-76.
43. Barker JN, Krepski TP, DeFor T, Davies SM, Wagner JE, Weisdorf DJ, et al. Searching for unrelated donor hematopoietic stem cell grafts: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002;8:257-60.
44. Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin PL, Driscoll TA, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 2003; 101:5061-7.
45. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105:1343-7.